A self-described “citizen journalist” who publishes “cynical and cranky” opinions about the Australian Stock Exchange on the Twitter account Stockswami cannot claim journalist privilege to protect his source, a judge has found.
The High Court on Friday denied special leave to three unions representing Qantas workers that sought to challenge a Federal Court ruling for the airline in a dispute over the operation of last year’s COVID-19 JobKeeper wage subsidy.
An appeals court has upheld a ruling which bars use of the RestQ trade mark on sleep products sold by Martin & Pleasance because of a “disturbing” number of similarities with the marketing and appearance of an established competitor’s Rescue natural sleep aid product.
A former CEO of a global pharmaceutical company has lost his appeal of a ruling throwing out a lawsuit he brought against his former employer after he was terminated in the wake of accusations that he harassed staff and using a syringe to stab multiple employees.
An employment solicitor representing a sacked Jetstar pilot must pay the airline’s legal costs in defending an appeal application “that ought never to have been made”, an appeals court has found.
The publisher of the Australian Financial Review has settled a defamation lawsuit by iSignthis CEO John Karantzis over an article by Rear Window columnist Joe Aston that allegedly falsely linked him to a money laundering scheme.
A former Telstra employee has lost her challenge to a ruling which denied her workers compensation for a hip injury suffered after a night out during a work trip, finding it did not arise out of her employment simply because it took place at the hotel booked by the telco.
A judge has issued an injunction temporarily barring use of the RestQ trade mark on sleep products sold by Martin & Pleasance because of a “disturbing” number of similarities with the marketing and appearance of an established competitor’s Rescue natural sleep aid product.
Swiss drug giant Novartis has sued generic drug maker Pharmacor to halt its launch of a generic version of the company’s top-selling MS drug Gilenya.
Seven Network has resolved a lawsuit brought by game show host and news presenter Simon Reeve seeking compensation and pecuniary penalties after his sudden dismissal in June during the height of the COVID-19 pandemic.